A Preliminary Study of Sublingual Fentanyl for the Management of Breakthrough Pain Analgesia in Patients With Advanced Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 29 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Jan 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 03 Feb 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018 as reported by ClinicalTrials.gov record.